J&J | Passifs Courants



Current Liabilities Changement Date
AbbVie USD 38.75B 4.31B 2024-12
Abbott USD 13B 1.15B 2025-03
Amgen USD 23.1B 2.79B 2024-12
AstraZeneca USD 29.13B 1.26B 2025-03
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
CONMED USD 278.13M 4.18M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Globus Medical USD 855.91M 37.85M 2024-12
Hologic USD 1B 34.8M 2024-12
Indivior 1.01B 66M 2025-03
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.01B 200.9M 2025-03
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 11.84B 355M 2025-01
Merck USD 28.42B 1.17B 2024-12
Merit Medical Systems USD 196.82M 19.58M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 288.18M 41.13M 2025-03
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12
Zoetis USD 3.41B 1.71B 2024-12



J&J Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.